EligibleTrials

Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients

Recruiting · NCT06108830 · Interventional (participants receive a specific treatment) · Lead sponsor: Tianjin Medical University General Hospital

View the official record on ClinicalTrials.gov →
Anxiety

Interventions studied

EsketamineEsketamine and remimazolamRemimazolamnormal saline

What this trial is about

To explore the effects of esketamine combined with remimazolam on postoperative sleep disturbance and anxiety in surgical patients undergoing gastroenteroscopies

Who can take part

Age range
20 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.